Abstract:Ankyrin repeat domain containing-protein 11 (ANKRD11), a transcriptional factor predominantly localized in the cell nucleus, plays a crucial role in the expression regulation of key genes by recruiting chromatin remodelers and interacting with specific transcriptional repressors or activators during numerous biological processes. Its pathogenic variants are strongly linked to the pathogenesis and progression of multisystem disorder known as KBG syndrome. With the widespread application of high-throughput DNA sequencing technologies in clinical medicine, numerous pathogenic variants in the ANKRD11 gene have been reported. Patients with KBG syndrome usually exhibit a broad phenotypic spectrum with a variable degree of severity, even if having identical variants. In addition to distinctive dental, craniofacial and neurodevelopmental abnormalities, patients often present with skeletal anomalies, particularly postnatal short stature. The relationship between ANKRD11 variants and short stature is not well-understood, with limited knowledge regarding its occurrence rate or underlying biological mechanism involved. This review aims to provide an updated analysis of the molecular spectrum associated with ANKRD11 variants, investigate the prevalence of the short stature among patients harboring these variants, evaluate the efficacy of recombinant human growth hormone in treating children with short stature and ANKRD11 variants, and explore the biological mechanisms underlying short stature from both scientific and clinical perspectives. Our investigation indicated that frameshift and nonsense were the most frequent types in 583 pathogenic or likely pathogenic variants identified in the ANKRD11 gene. Among the 245 KBGS patients with height data, approximately 50% displayed short stature. Most patients showed a positive response to rhGH therapy, although the number of patients receiving treatment was limited. ANKRD11 deficiency potentially disrupts longitudinal bone growth by affecting the orderly differentiation of growth plate chondrocytes. Our review offers crucial insights into the association between ANKRD11 variants and short stature and provides valuable guidance for precise clinical diagnosis and treatment of patients with KBG syndrome.

High frequency of pathogenic ACAN variants including an intragenic deletion in selected individuals with short stature

A High Proportion of Novel <i>ACAN</i> Mutations and Their Prevalence in a Large Cohort of Chinese Short Stature Children

Novel Pathogenic ACAN Variants in Non-Syndromic Short Stature Patients.

Clinical Characteristics of Pathogenic ACAN Variants and 3-Year Response to Growth Hormone Treatment: Real-World Data

Genotype and phenotype in patients with ACAN gene variants: Three cases and literature review

A rare ACAN non-canonical splicing-site intron variant results in familial short stature

Familial Short Stature Caused by ACAN Gene Mutation:A Familial Case Report

Novel aggrecan variant, p. Gln2364Pro, causes severe familial nonsyndromic adult short stature and poor growth hormone response in Chinese children.

ACAN Gene Mutations in Short Children Born SGA and Response to Growth Hormone Treatment

Genetic studies of 77 cases of short stature with unknown etiology

Case analysis and literature review of 3 children with short stature with ACAN gene mutation

Growth-Promoting Therapies May Be Useful in Short Stature Patients with Nonspecific Skeletal Abnormalities Caused by Acan Heterozygous Mutations: Six Chinese Cases and Literature Review

A wide range of protective and predisposing variants in aggrecan influence the susceptibility for otosclerosis

A rare case of skeletal dysplasia: biallelic variant in ACAN gene

FGD1 Variant Associated with Aarskog–Scott Syndrome

Short Stature in Klinefelter Syndrome From Aggrecan Mutation

Genetic analysis of the PAPP-A2 gene and evaluation of free IGF-1, IGFBP-5, and ALS concentrations in a group of 22 patients with idiopathic short stature

Dual Diagnosis of Osteogenesis Imperfecta (OI) and Short Stature and Advanced Bone Age with or Without Early-Onset Osteoarthritis And/or Osteochondritis Dissecans (SSOAOD) Reveals a Cumulative Effect on Stature Caused by Mutations in COL1A1 and ACAN Genes.

Insights into the ANKRD11 variants and short-stature phenotype through literature review and ClinVar database search

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Genetic Findings in Short Turkish Children Born to Consanguineous Parents